TABLE 1.
Correlations between lncARSR expression and clinical features in 89 CRC patients
| Characteristics | No. of patients (%) | lncARSR expression | P‐value* | |
|---|---|---|---|---|
| Low n = 34 (%) | High n = 55 (%) | |||
| Age | ||||
| <65 | 42 (47.2) | 15 (44.1) | 27 (49.1) | .669 |
| ≥65 | 47 (52.7) | 19 (55.9) | 28 (50.9) | |
| Gender | ||||
| Female | 41 (46.1) | 16 (47.1) | 25 (45.5) | .883 |
| Male | 48 (53.9) | 18 (52.9) | 30 (54.5) | |
| Location | ||||
| Left | 50 (56.2) | 17 (50) | 33 (60.0) | .386 |
| Right | 39 (43.8) | 17 (50) | 22 (40.0) | |
| pT stage | ||||
| T1 | 3 (3.4) | 2 (5.9) | 1 (1.8) | .563 |
| T2 | 19 (21.3) | 8 (23.5) | 11 (20.0) | |
| T3 | 40 (44.9) | 16 (47.1) | 24 (43.6) | |
| T4 | 27 (30.3) | 8 (23.5) | 19 (34.5) | |
| Lymph node metastasis | ||||
| N0 | 52 (58.4) | 30 (88.2) | 22 (40.0) | .001* |
| N1 | 27 (30.3) | 2 (5.9) | 25 (45.5) | |
| N2 | 10 (11.2) | 2 (5.9) | 8 (14.5) | |
| Distant metastasis | ||||
| M0 | 82 (92.1) | 34 (100) | 48 (87.3) | .029* |
| M1 | 7 (7.9) | 0 (0) | 7 (12.7) | |
| AJCC stage | ||||
| I | 15 (16.9) | 9 (26.5) | 6 (10.9) | .037* |
| II | 37 (41.6) | 17 (50) | 20 (36.4) | |
| III | 30 (33.7) | 7 (20.6) | 23 (41.8) | |
| IV | 7 (7.9) | 1 (2.9) | 6 (10.9) | |
| Differentiation | ||||
| Well | 20 (22.5) | 11 (32.4) | 9 (216.4) | .211 |
| Moderate | 38 (42.7) | 13 (38.2) | 25 (44.4) | |
| Poor | 31 (34.8) | 10 (29.4) | 21 (38.2) | |
*
P < .05 significant difference.